VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Bisphosphonate treatment
Preclinical
Small molecule
U
Université Catholique de Louvain
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Paget's Disease of Bone
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Paget's Disease of Bone
Preclinical
Completed
Clinical
Trials by Indication
[1]
Muscular Dystrophy
1 trial
Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy
Completed
·
G
Gilles Boire
·
Phase 4
·
NCT01882400
·
11 enrolled
Paget's Disease of Bone
1 trial
18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
Completed
·
U
Université Catholique de Louvain
·
N/A
·
NCT00306046
·
20 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Bisphosphonate treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Bisphosphonate treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Bisphosphonate treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Université Catholique de Louvain company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
Université Catholique de Louvain
Related News